A platform of patient-derived microtumors identifies therapeutic vulnerabilities in ovarian cancer.
N. Anderle, A. Koch, B. Gierke…·C. Schmees
This paper develops a 3D patient-derived microtumor platform to identify therapeutic vulnerabilities in ovarian cancer by testing drug responses and immune cell interactions.